Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage ; volume:12 ; number:1 ; day:29 ; month:9 ; year:2020 ; pages:1-12 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (29.9.2020), 1-12, 12.2020
- Urheber
-
Bousiges, Olivier
Philippi, Nathalie
Lavaux, Thomas
Perret-Liaudet, Armand
Lachmann, Ingolf
Schaeffer-Agalède, Caroline
Anthony, Pierre
Botzung, Anne
Rauch, Lucie
Jung, Barbara
Sousa, Paulo Loureiro de
Demuynck, Catherine
Martin-Hunyadi, Catherine
Cretin, Benjamin
Blanc, Frédéric
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-020-00684-5
- URN
-
urn:nbn:de:101:1-2020111620214688124151
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bousiges, Olivier
- Philippi, Nathalie
- Lavaux, Thomas
- Perret-Liaudet, Armand
- Lachmann, Ingolf
- Schaeffer-Agalède, Caroline
- Anthony, Pierre
- Botzung, Anne
- Rauch, Lucie
- Jung, Barbara
- Sousa, Paulo Loureiro de
- Demuynck, Catherine
- Martin-Hunyadi, Catherine
- Cretin, Benjamin
- Blanc, Frédéric
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
α-synuclein in the pathophysiology of Alzheimer’s disease
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
α-synuclein in the pathophysiology of Alzheimer’s disease
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
α-synuclein in the pathophysiology of Alzheimer’s disease